Medifast Inc (MED) stock
MEDNYSEMiscellaneous Food Preparations & Kindred ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 10/3057% below fair value
$12.19−0.35 (-2.79%)
Close on Nov 17, 2026Market cap $136.32MP/E –Yield 0.00%
Medifast operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Medifast's operating cash flow for the twelve months ending Sep 30, 2026 was -$26.00K, down 100.4% year over year. For fiscal 2025 it was $6.86M, down 72.0% from the year before. Over ten years it grew -13.5% a year on average. The highest annual figure on record is $194.57M in fiscal 2022.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.86M | -72.0% |
| FY2024 | Dec 31, 2024 | $24.48M | -83.4% |
| FY2023 | Dec 31, 2023 | $147.66M | -24.1% |
| FY2022 | Dec 31, 2022 | $194.57M | +105.8% |
| FY2021 | Dec 31, 2021 | $94.55M | -34.9% |
| FY2020 | Dec 31, 2020 | $145.20M | +72.3% |
| FY2019 | Dec 31, 2019 | $84.26M | +38.6% |
| FY2018 | Dec 31, 2018 | $60.82M | +40.7% |
| FY2017 | Dec 31, 2017 | $43.24M | +70.6% |
| FY2016 | Dec 31, 2016 | $25.35M | -13.8% |
| FY2015 | Dec 31, 2015 | $29.41M | +15.2% |
| FY2014 | Dec 31, 2014 | $25.54M | -39.7% |
| FY2013 | Dec 31, 2013 | $42.36M | +5.2% |
| FY2012 | Dec 31, 2012 | $40.26M | +15.5% |
| FY2011 | Dec 31, 2011 | $34.87M | +21.2% |
| FY2010 | Dec 31, 2010 | $28.77M | +50.2% |
| FY2009 | Dec 31, 2009 | $19.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $3.30M | -72.8% |
| Q2 FY2026 | Jun 30, 2026 | $1.70M | – |
| Q1 FY2026 | Mar 31, 2026 | $260.00K | -92.4% |
| Q4 FY2025 | Dec 31, 2025 | -$5.28M | – |
| Q3 FY2025 | Sep 30, 2025 | $12.11M | +33.5% |
| Q2 FY2025 | Jun 30, 2025 | -$3.38M | -125.8% |
| Q1 FY2025 | Mar 31, 2025 | $3.41M | -53.2% |
| Q4 FY2024 | Dec 31, 2024 | -$4.95M | -147.0% |
| Q3 FY2024 | Sep 30, 2024 | $9.07M | -69.7% |
| Q2 FY2024 | Jun 30, 2024 | $13.07M | -69.7% |
| Q1 FY2024 | Mar 31, 2024 | $7.28M | -88.6% |
| Q4 FY2023 | Dec 31, 2023 | $10.52M | -79.7% |
| Q3 FY2023 | Sep 30, 2023 | $29.93M | -46.0% |
| Q2 FY2023 | Jun 30, 2023 | $43.15M | -1.4% |
| Q1 FY2023 | Mar 31, 2023 | $64.06M | +46.7% |
| Q4 FY2022 | Dec 31, 2022 | $51.74M | – |
| Q3 FY2022 | Sep 30, 2022 | $55.40M | +250.6% |
| Q2 FY2022 | Jun 30, 2022 | $43.76M | +109.6% |
| Q1 FY2022 | Mar 31, 2022 | $43.67M | -33.1% |
| Q4 FY2021 | Dec 31, 2021 | -$7.46M | -137.6% |
| Q3 FY2021 | Sep 30, 2021 | $15.80M | -61.6% |
| Q2 FY2021 | Jun 30, 2021 | $20.88M | -63.7% |
| Q1 FY2021 | Mar 31, 2021 | $65.33M | +144.3% |
| Q4 FY2020 | Dec 31, 2020 | $19.83M | +3.5% |
| Q3 FY2020 | Sep 30, 2020 | $41.11M | +129.7% |
| Q2 FY2020 | Jun 30, 2020 | $57.52M | +297.3% |
| Q1 FY2020 | Mar 31, 2020 | $26.74M | -18.3% |
| Q4 FY2019 | Dec 31, 2019 | $19.15M | +24.9% |
| Q3 FY2019 | Sep 30, 2019 | $17.90M | +157.6% |
| Q2 FY2019 | Jun 30, 2019 | $14.48M | -29.5% |
| Q1 FY2019 | Mar 31, 2019 | $32.73M | +81.8% |
| Q4 FY2018 | Dec 31, 2018 | $15.34M | +53.6% |
| Q3 FY2018 | Sep 30, 2018 | $6.95M | -44.4% |
| Q2 FY2018 | Jun 30, 2018 | $20.52M | +45.9% |
| Q1 FY2018 | Mar 31, 2018 | $18.01M | +169.5% |
| Q4 FY2017 | Dec 31, 2017 | $9.98M | – |
| Q3 FY2017 | Sep 30, 2017 | $12.51M | – |
| Q2 FY2017 | Jun 30, 2017 | $14.07M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.68M | – |
| Q4 FY2016 | Dec 31, 2016 | -$315.00K | – |
See a number that looks wrong?